An observational, patient‐reported outcome study of sleep quality and depression among individuals with overactive bladder syndrome
Neurourology and Urodynamics · 2024
DOI: 10.1002/nau.25348 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Sally Jensen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Department of Medical Social Sciences, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Astellas Pharma Global Development.
Themen: Schlaf, Depression
Abstract (Originalsprache)
Introduction
Overactive bladder (OAB) can adversely affect health‐related quality‐of‐life (HRQoL) and adherence to treatments; however, the extent of their association is unknown. This study sought to characterize Sleep Disturbance, Depression, Fatigue, and patient‐reported medication adherence among adults with OAB in the United States. Materials and Methods In this descriptive, observational study, patients completed patient‐reported outcome (PRO) measures of urinary symptoms, anxiety, depression, fatigue, sleep quality, and medication adherence. PRO scores were compared across age, sex, body mass index, and sleep and antidepressant medication‐taking subgroups. Exploratory analyses compared PRO scores between groups and estimated the effect size of differences.
Results
Of 1013 patients contacted, 159 completed the assessments (female: 67.3%; ≥65 years of age: 53.5%; most severe OAB symptom: nocturia). Scale scores for Sleep Disturbance, Fatigue, and Depression were consistent with US population norms. No correlations of moderate or greater magnitude were observed between the severity of lower urinary tract symptoms and Sleep Disturbance, Fatigue, or Depression. When comparing individuals receiving antidepressants with those who were not, almost all outcomes including urinary symptoms, anxiety, and depression were significantly worse. Patients taking antidepressants also had poorer adherence to their OAB medications.
Conclusion
In this cohort of individuals with OAB, Sleep Disturbance, Fatigue, and Depression scores were in line with general population reference values; however, among the subgroups analyzed, patients on antidepressants had worse HRQoL and more substantial impacts on medication adherence, highlighting the importance of the assessment and management of depression in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwestern University Feinberg School of Medicine, Department of Medical Social Sciences, Chicago, Illinois, USA.
- Astellas Pharma Global Development Inc., Northbrook, Illinois, USA.
- Northwestern Medicine, Chicago, Illinois, USA.
- NorthShore University HealthSystem, Evanston, Illinois, USA.
Förderung
- Astellas Pharma Global Development
Zitieren
APA
Jensen, S., Walker, D., Elsouda, D., Lockefeer, A., Kenton, K., Peipert, J. D., Jackson, K. L., Helfand, B. T., Glaser, A. P., & Cella, D. (2024). An observational, patient‐reported outcome study of sleep quality and depression among individuals with overactive bladder syndrome. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25348
Vancouver
Jensen S, Walker D, Elsouda D, Lockefeer A, Kenton K, Peipert JD, et al. An observational, patient‐reported outcome study of sleep quality and depression among individuals with overactive bladder syndrome. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25348
BibTeX
@article{Jensen2024,
author = {Jensen, Sally and Walker, David and Elsouda, Dina and Lockefeer, Amy and Kenton, Kimberly and Peipert, John Devin and Jackson, Kathryn L and Helfand, Brian T and Glaser, Alexander P and Cella, David},
title = {An observational, patient‐reported outcome study of sleep quality and depression among individuals with overactive bladder syndrome},
journal = {Neurourology and Urodynamics},
year = {2024},
doi = {10.1002/nau.25348}
}
EUVIMED